Amyloid aggregates have been linked to the onset of multiple human neurodegenerative diseases, including Alzheimer's disease, Parkinson disease and type II diabetes. The detection of these aggregates is critical for understanding the mechanism and factors that lead to aggregation. In the recent decades, photoluminescence spectroscopy has been utilized to study amyloid aggregation, allowing the development of interesting therapeutic and diagnostic strategies. With the advancement of photoluminescence spectroscopy, metal complexes have led to the detection of amyloid aggregates due to their distinct properties. In the presence of amyloid aggregates, these metal complexes exhibit specific responses such as intensity changes, shift in emission wavelength, variations in lifetime and anisotropy changes. In this minireview, we provide an overview of the photoluminescent metal complexes used for the detection of amyloid aggregates, including Ru(II), Re(I), Ir(III) and Pt(II) complexes.